Amandine Pelletier is currently employed as an Ingénieur d’études at CNRS within the CRCM, Équipe MODESTI, focusing on homologous recombination, NHEJ, and genomic integrity since September 2024. Previously, Amandine worked as a Scientist at Akamis Bio from February 2022 to May 2024, contributing to the in vitro generation and characterization of oncolytic adenovirus-based therapy candidates. Prior experience includes a position as an Associate Scientist in Molecular Virology at VIVEbiotech in 2021, where Amandine was involved in engineering and characterizing cell lines for lentiviral vector production optimization. Additionally, Amandine completed internships at Les vignobles Carrère and Université Paul Sabatier Toulouse III, the latter focusing on fundamental research regarding asymmetry in zebrafish brains. Amandine holds a Diplôme d'ingénieur in Biotechnology from ENSTBB Bordeaux INP, completed in 2021, and pursued studies at La Prépa des INP and Lycée Marguerite de Valois.